Related Experiment Video
Updated: Aug 9, 2026

Measuring Nitrite and Nitrate, Metabolites in the Nitric Oxide Pathway, in Biological Materials using the Chemiluminescence Method
Published on: December 25, 2016
Nitrate tolerance. How to prevent it or minimize its effect
1Cardiology Section, University of Oklahoma Health Sciences Center, Oklahoma City 73104.
Abstract:
Continuous therapy with nitrates rapidly produces tolerance along with loss or diminution of circulatory, antianginal, and anti-ischemic effects. Development of tolerance can be avoided by various approaches. In patients with stable angina, intermittent use of nitrates with long nitrate-free intervals, use of transdermal nitroglycerin during the day or oral isosorbide dinitrate or isosorbide-5-mononitrate twice daily in the morning and early afternoon, and intermittent use of nitrates in combination with another class of antianginal agent are appropriate. In patients with unstable angina, continuous therapy with intravenous nitroglycerin is recommended during the acute phase of angina. Despite development of partial tolerance, oral isosorbide dinitrate, 30 to 60 mg four times a day, plus hydralazine may be useful for patients with congestive heart failure who cannot tolerate angiotensin-converting enzyme inhibitors. Concomitant use of sulfhydryl donors or angiotensin-converting enzyme inhibitors, agents that might theoretically prevent nitrate tolerance, is not recommended. Data on these agents are conflicting, and added costs and adverse effects are likely to preclude their use in the future.
Insights
Nitrate tolerance diminishes antianginal effects. Intermittent nitrate use or combination therapy can prevent tolerance in stable angina. Continuous intravenous nitroglycerin is used for unstable angina.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Continuous nitrate therapy leads to rapid tolerance, reducing circulatory, antianginal, and anti-ischemic effects.
- Nitrate tolerance is a significant clinical challenge in managing angina and heart failure.
Purpose of the Study:
- To review strategies for avoiding or managing nitrate tolerance.
- To outline appropriate nitrate use in stable angina, unstable angina, and congestive heart failure.
Main Methods:
- Review of existing literature on nitrate therapy and tolerance.
- Analysis of different dosing regimens and combination therapies for angina management.
Main Results:
- Intermittent nitrate use with nitrate-free intervals is effective for stable angina.
- Transdermal nitroglycerin or specific oral nitrate regimens can mitigate tolerance.
- Intravenous nitroglycerin is recommended for acute unstable angina.
- Oral isosorbide dinitrate plus hydralazine may benefit heart failure patients with ACE inhibitor intolerance.
Conclusions:
- Nitrate tolerance can be effectively managed through strategic dosing and combination therapies.
- Specific approaches are recommended for stable angina, unstable angina, and heart failure.
- Concomitant use of sulfhydryl donors or ACE inhibitors to prevent tolerance is not currently recommended due to conflicting data and potential adverse effects.
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Angina IV: Management
Inorganic Nitrogen Assimilation

